American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society
Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk …

A Critical Appraisal of Implantable Cardioverter-Defibrillator Therapy for the Prevention of
Sudden Cardiac Death Roderick Tung, Peter Zimetbaum, Mark E. Josephson The …

Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …

Since the inception of the Canadian Cardiovascular Society heart failure (HF) guidelines in
2006, much has changed in the care for patients with HF. Over the past decade, the HF …

Background Implantable cardioverter–defibrillator (ICD) therapy has been shown to improve
survival in patients with various heart conditions who are at high risk for ventricular …

Objectives: This phase I trial was designed to assess the feasibility and safety of autologous
skeletal myoblast transplantation in patients with severe ischemic cardiomyopathy …

Downloaded from scores the need for risk stratification techniques to identify patients at high
risk for these events and effective interventions that can prevent or abort these events …

Objectives: The study was designed to develop a simple risk stratification score for primary
therapy with an implantable cardioverter-defibrillator (ICD). Background: Current guidelines …

The implantable cardioverter defibrillator (ICD) has emerged as an important treatment
option for selected patients who are at risk of sudden cardiac death. Randomized trials have …

Objectives: The purpose of this study was to determine the efficacy of implantable cardiac
defibrillator (ICD) therapy in preventing sudden cardiac death (SCD) in post-infarction …